Press Archive
Full archive of news, press releases & blogs about BIOLIFE4D.

 

Latest Press Releases


Pioneering biotech company reaches significant milestone well ahead of 6-8 month development time, successfully 3D bioprinting a human cardiac patch, as it seeks to produce full human hearts viable for transplant CHICAGO – June 25, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today…


Company surpasses $1M in accepted investments; expects to make significant scientific announcement in the near future CHICAGO – June 22, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying its Regulation A+ (Mini-IPO) offering, effective June 22, 2018, following…


Houston location provides access to state-of-the-art equipment and support, and close proximity to world class academic research facilities within local university medical and science centers, as Company continues development of groundbreaking bioprinting technology CHICAGO – May 29, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for…


Agreement provides access to world class academic research facilities and resources, including sophisticated imaging and instrumentation capabilities, as Company continues development of groundbreaking bioprinting technology CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a Laboratory…


Pioneering biotech company seeks investors in innovative technology to enable the 3D bioprinting of human hearts viable for transplant; investors of $100,000 or more will witness initial heart transplant firsthand CHICAGO – February 1, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced…


Healthcare 3D printing market projected to reach $2.2B by 2024, driven by applications in tissue engineering and regenerative medicine; Company prepares to take investments for its pioneering 3D bioprinting technology. CHICAGO, Jan. 17, 2018  — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on the…


Company adds renowned stem cell expert from the Texas Heart Institute to lead research as it continues development of its lifesaving heart transplant technology CHICAGO – January 2, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr. Ravi Birla…


Company taking indications of interest for upcoming Regulation A+ offering during season of giving; investments in BIOLIFE4D to push forward innovation of life saving heart transplant technology CHICAGO – December, 20, 2017 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is taking…


New report from the American College of Cardiology/American Heart Association Task Force states 46% of Americans have high blood pressure CHICAGO – December, 5, 2017 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on a new report from the American College of Cardiology/American…


NYC firm to help Company generate awareness for its life saving 3D bioprinting technology as it prepares to launch its Regulation A+ equity crowdfunding campaign CHICAGO – November, 30, 2017 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has retained FischTank Marketing…


Chicago, Ill., Nov. 13, 2017 — Biotech pioneer BIOLIFE4D is reporting significant progress in its quest to become the first company to bioprint a fully functional and transplantable human heart, tapping regenerative medicine and biomedical engineering veteran Adam W. Feinberg, Ph.D. to lead its accomplished Scientific Advisory Team. “BIOLIFE4D is focused and working incredibly hard,…


Chicago, Ill., Sept. 22, 2017 — Complementing the acclaimed talent already assembled on its scientific leadership team, bioprinting startup BIOLIFE4D announced the addition of Raimond Winslow, Ph.D. whose vast expertise will help the company deliver on its mission to 3D bioprint a viable human heart suitable for transplant. Winslow’s new role at BIOLIFE4D comes in…


Chicago, Ill., Sept. 15, 2017 — Bioprinting startup BIOLIFE4D has named accomplished thoracic and cardiac surgeon Jeffrey Morgan M.D., FACS, FACC as Chief Medical Officer, further bolstering its world-class leadership team. BIOLIFE4D is a pioneering biotech company focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable…


Chicago, Ill., Sept. 6, 2017 — BIOLIFE4D announced it filed a $50 million initial public offering with the Securities and Exchange Commission (SEC) under Regulation A+ rules, allowing everyday investors to help the company bring its groundbreaking cardiac tissue regeneration and organ replacement process to market. Chicago-based BIOLIFE4D is a pioneering biotech company focused on…

Blogs


The first heart transplant in human history took place on December 3, 1967, which means earlier this week we celebrated the 51st anniversary of the heart transplant. The heart transplant process has improved significantly in that time, perhaps most importantly the survival rate of transplant recipients. However, one aspect that still requires improvement is the…


The end-of-year holiday season brings families and friends together, and many people will be asked by loved ones what they would like to receive as gifts. These gifts can thoughtfully demonstrate an understanding of what the recipients enjoy or what matters most to them. To find these gifts, many people will head to shopping malls or…


If you’re reading this, it is because you’ve lived healthily enough to reach another Thanksgiving. Everyone is thankful for something and in this case, you may be thankful that you and your loved ones are all together once more. None of this would be possible, though, without beating hearts. Unfortunately, there is a shortage of…


Many people know someone who – for one reason or another – wishes they invested in a company very early in its existence. One of the major benefits of investing in a company early is that if it’s successful, you will likely have bought in at a low price and your securities will be worth…


Less than six months ago we announced our residency at the Johnson & Johnson Innovation JLABS at the renowned Texas Medical Center in Houston, Texas. Since that time, through the access of state-of-the-art equipment and support, we have been able to accelerate our scientific roadmap, successfully 3D bioprinting a human cardiac patch significantly ahead of schedule. Following…


In addition to working on our 3D bioprinted mini human heart, October has been a busy month for BIOLIFE4D with media coverage in the Houston Chronicle, Arkansas Democrat-Gazette, Medical Device and Diagnostics Industry (MDDI) and 3Dnatives. We’re thrilled with the continued support of our efforts, and hope our investors feel the same way. Whether you’re…


As humans have evolved, so too has our understanding of our bodies and how we can enhance, repair or extend life. Since the dawn of time, humanity has encountered disease and other external circumstances that require medical innovation and care. Even for seemingly irreplaceable parts of the body and organs, we have a knack for…


Diversification is a widely-practiced investment strategy in which investors and asset managers assemble portfolios containing various stocks and other kinds of assets – some high-risk, low-risk and even passion projects for social good – to increase their chances at greater returns. You may be a savvy investor, but chances are your portfolio doesn’t already include securities…


Earlier this year, BIOLIFE4D established operations in Houston, Texas, to continue developing our medical technology, and to take significant strides toward our goal of 3D bioprinting a human heart viable for transplant. As a Johnson & Johnson JLABS resident at Texas Medical Center, we have access to world-class laboratory facilities, making the city of Houston’s…


Investments come in many different forms – real estate, stocks, bonds and crowdfunding, to name a few. Across all forms, a movement gaining a lot of momentum in recent years has been ethical investing. Ethical investing often involves avoiding investments in controversial companies or projects. Many advisors and retirement plans offer ethical investing options that will…


In case you didn’t already know, this Saturday, September 29 marks World Heart Day. Created by the World Heart Federation, this date serves to raise awareness of cardiovascular disease, the world’s leading killer. This education centers around preventative measures individuals can take to reduce their own risk of cardiovascular disease – like diet and exercise – but…


We’ve recently shared more recognition of BIOLIFE4D and our scientific innovation in the global media, as outlets like BBC showcased our life-saving technology. Today we’re pleased to announce that we were recently recognized as a nominee for the 17th Annual Chicago Innovation Awards, held each year to celebrate innovators within the Chicago-ecosystem. BIOLIFE4D was nominated in…


Summer may be winding down, but BIOLIFE4D’s efforts to 3D bioprint a human heart viable for transplant are not and the media has taken notice. These efforts have attracted international attention, as evidenced by recent features in the BBC and on Verdict. We haven’t forgotten our roots, though, as 3DPrint.com and Medical Device Network have…


In addition to marking the end of summer and bringing cooler weather in many places, September is Healthy Aging Month and a great time to think about how you can age like a fine wine. Your heart is perhaps the most important organ in your body and if you want it to take care of you,…


As BIOLIFE4D works to 3D bioprint a full-size human heart viable for transplant, we have an opportunity to complete several incremental achievements, each of which not only validates our technology and process but also provides huge market potential while on our way to developing the full heart. Scientifically, one of our first steps was to…


Although humans have been transplanting hearts for 50 years, a heart transplant is still an incredibly complicated procedure posing some major challenges – the available supply of transplantable hearts, getting a recipient’s body to accept another human being’s heart, and having world-class medical facilities and personnel to execute the procedure. The heart is one of,…


As you are probably aware by now, one of the greatest challenges facing the organ transplant industry is a shortage of organs available for transplant. It’s possible to live without some organs – like kidneys – and so those can be donated by living donors. However, most organs are vital, and are required for survival….


When BIOLIFE4D successfully 3D bioprinted human cardiac tissue, two of the main reasons we were excited were that it’s obviously a significant medical milestone, and because we did it well ahead of our initial schedule. With that said, we’ve followed it up by aiming even higher, and are now laser-focused in our labs on 3D…


As of April 2018, the U.S. organ transplant waiting list was about 114,000 names long, while less than 35,000 transplants were performed in 2017. Overall, about one third of the total demand is being met, and when that happens, people often resort to illegal means to secure organs. As a result, 5-10% of all organ transplants…


At BIOLIFE4D, we’re working to 3D bioprint human organs viable for transplant from patients’ own cells. That work is very complex and quite frankly, so is the market for this kind of technology. Each year, many different types of organs are transplanted, each of which are affected by unique supply challenges and thus present different…


In case you missed it, BIOLIFE4D recently successfully demonstrated its ability to 3D bioprint human cardiac tissue derived from stem cells, which it had reprogrammed from an individual’s specialized cells into the different types of heart cells needed to bioengineer a human heart. And astonishingly, we 3D bioprinted our human cardiac patch more than a year…


Since we announced our Regulation A+ equity crowdfunding campaign back in February, we have been met with tremendous support and enthusiasm from individuals who felt connected to the cause and wanted to help. Nearly five months later the support from our investors continues, but we’ve also attracted a host of new eyes toward our company…


It’s been a hot week as we roll in to July, and BIOLIFE4D set off some early fireworks with media features in two prominent publications – Popular Mechanics and Crain’s Chicago Business! Both of these highly influential news outlets featured our scientific milestone achievements from last week. We couldn’t be more proud to see the…


Earlier this week, we shared with the world that BIOLIFE4D has achieved an incredible scientific milestone, having successfully 3D bioprinted human cardiac tissue. In the days since the announcement, we’ve received tremendous feedback and the world has certainly taken notice. Below are a selection of some of the pieces of media coverage we’ve achieved this…


We are extremely excited to announce that BIOLIFE4D has successfully demonstrated its ability to 3D bioprint viable human cardiac tissue – specifically, a human cardiac patch.  And what is just as incredible it that our science team, which is located at the prestigious research facility at JLABS, was able to accomplish this feat far ahead…


Today is an exciting day for BIOLIFE4D. After just a few months and more than $1M in investments raised, we’re pleased to announce that we’ve modified our Regulation A+ (Mini-IPO) offering due to popular demand and that the stock price has now reached $12 per share – a 20% increase in just four months. Since…


BIOLIFE4D stands on the precipice of a technology breakthrough that we truly believe will alter the way potential partners and investors consider our company. From Day 1, we have done our best to outline a clear strategy so that our shareholders, partners and interested parties would understand our vision. From there, it has been on us…


It is with great pleasure that I announce the opening of BIOLIFE4D research labs at JLABS, within the Texas Medical Center, Houston. After several months of strategy planning, BIOLIFE4D is now positioned in the heart of the world’s largest medical center, Texas Medical Center. Houston is the mecca of heart research and is home to…


The last several months have been an incredible time for BIOLIFE4D. In February, we launched our equity crowdfunding campaign to help in our mission to 3D bioprint viable treatment alternatives to cardiac issues, like patches, valves, and full hearts for transplant. Our scientific achievements are progressing rapidly, and the media has certainly taken notice. We have…


You’ve likely heard that BIOLIFE4D is currently raising funds to 3D bioprint transplantable human hearts, valves, and other organs. In order to do that, we need people like you to be aware of what we’re working towards. If these stories have you excited and you want to spread the word, we’d love you to share…


When investing, it is important to consider companies and ventures that address common problems. Unfortunately, heart disease is an extremely common problem, as in the U.S. it kills one in three women and one in four men each year. In the developed world as a whole, it kills one in three people. Because there are…


If you’re like many Americans, you may have recently received your federal and state tax returns. People use these sudden windfalls of money for lots of different things. Some spend it all in short shopping sprees, while others use it to pay bills or stow it away in savings. If you’re interested in improving your…


As many know, February was American Heart Month. First recognized in 1964, Heart Month has gone on to serve as a reminder to Americans how important heart health is to themselves, their families, and their friends. It’s an important reminder too – heart disease is the #1 killer of men and women in the U.S….


This Sunday, April 15 is Good Deeds Day, when people celebrate by doing good deeds for others and for the world. Established in 2007, Good Deeds Day has become an annual tradition in 93 countries, based on the idea that everyone is capable of doing good. In 2017, 2.5 million participants helped with about 20,000…


BIOLIFE4D is pleased to announce today the availability of two new investment methods – mobile device and debit/credit cards! Investing in BIOLIFE4D has never been easier, as we have now expanded our solutions to provide investors with multiple options for investment. Mobile Devices  In addition to laptop and desktop computers, investors can now utilize their…


Aside from the recent holidays and April fools, this week also officially kicked off National Donate Life Month, a period dedicated to encouraging Americans to register as organ, eye and tissue donors and to honor those donors who have impacted the lives of others. According to the Organ Procurement and Transplantation Network, every ten minutes,…


As of March 21, spring is in the air. On top of taking advantage of the warmer weather and additional daylight, people like to clean. People clean their cars, yards, floors, gutters, closets – you name it. But this year, why don’t you make it a goal to spring clean your arteries, your heart, and…


By now you’re aware of BIOLIFE4D’s mission to transform the way heart disease is treated and to save lives by innovating the transplant process. Through our revolutionary 3D bioprinting process, we will produce viable human organs for transplant and provide a higher quality of life for patients. However, there is another group that we are…


Last Sunday the majority of the United States observed Daylight Savings Time, which for many means we’re getting closer to Spring and warmer weather. For one night though, it also meant one less hour of sleep (to the chagrin of many). Daylight Savings Time can affect sleeping rhythms, as it gets dark later and light…


It’s been about a month since we opened up our Regulation A+ equity crowdfunding campaign for investment and as our CEO Steve Morris noted recently, the response has been incredible. We’ve been accepting new investments every day and our group of public shareholders is growing! It really has been an incredible few weeks. To date,…


As warmer weather approaches (for those of us in multi-seasonal areas), stepping outside becomes more enticing. Many of us have likely spent the colder months hibernating inside, indulging on too many delicious holiday snacks. Even if you’re not ready to get working on your beach bod, now is a great time to get back outside…


Two weeks ago, we took a significant step toward our mission of revolutionizing treatment for heart disease when we launched our Regulation A+ equity crowdfunding campaign. The decision to allow outside investment by the general public into BIOLIFE4D was an easy one. Heart disease has touched the lives of tens of millions of people across…


It’s that time of the year again: Valentine’s Day when we celebrate our significant others, loved ones, and families. It’s also Heart Month! Since love is such a major theme of this holiday and of this time of year, we’ve put together a list of eight songs – some older, some newer – that will…


February is an important time of year for the heart, but not for the reason you might be thinking of. Sure, there’s that holiday about love and emotions from the heart, but we’re talking about something much more significant. February is American Heart Month – sponsored by The American Heart Association – and is the…


Heart failure and losing a loved one to sudden cardiac arrest is emotionally draining and something that no one should ever have to experience. Sadly, too many of us have been through this experience. The disparity between donor hearts and the number of patients requiring a heart transplant is staggering. There are only 3,000 donor…


It was December 24, 2014 when I first heard the words “heart failure.”  I wasn’t feeling great but by no means did I think it was anything serious. I prided myself on healthy living and eating. January, 2015 was when I was first hospitalized for my condition and spent a total of 66 days in…


While many people associate cold weather dangers with hypothermia or frostbite, there’s more to it. According to Northwestern Medicine, falling temperatures increase risks for heart attacks. It can create dangerous combinations of cardiovascular risks, so it’s important to take steps to protect yourself. Like heart transplant waiting lists, winter heart health is a supply and…


Advocate for 3D Bioprinting

*** The following contribution is from Virgil Anderson, a tireless advocate for awareness around workplace asbestos exposure, as well as someone who was diagnosed with mesothelioma *** 3D printing is revolutionizing many industries, but the possibility that this technology could print cells, tissues, and organs for human patients is perhaps the most exciting application. In fact,…


At each year’s end, people resolve to improve in certain aspects of their lives and make the new year better than the last. These resolutions range from financial to physical, and everything in between. If you need help with your resolution, allow BIOLIFE4D to recommend one: better heart health. If you take care of your…


Jack Radandt was born with a rare condition called Hypoplastic Left Heart Syndrome.  The condition is a congenital heart defect affecting normal blood flow through the heart. Jack’s heart reconstruction process began at 10 days old, and his remaining two surgeries were performed before he reached the age of three.  After the surgeries, he triumphed…


Ah, the holidays have finally arrived! Hanukah, Christmas, Kwanza, then New Year’s Eve and New Year’s Day itself are just around the corner. One of the best parts about the holiday season is the setting. In many parts of the United States and the Western Hemisphere snow falls and fireplaces are lit. This, coupled with…


The medical uses for 3D bioprinting are expanding rapidly and are expected to revolutionize health care.  Medical uses for 3D bioprinting can be seen within several broad categories, including tissue and viable human organ fabrication. These applications for 3D bioprinting can provide many benefits could include the customization and personalization of the actual tissue and organs using…


Earlier this week, on December 3, 2017, the medical community celebrated the 50th anniversary of one of the most historic events ever – the first ever human heart transplant. It’s been 50 years since Dr. Christiaan Barnard performed the procedure on 53-year old Lewis Washkansky, a South African grocer dying of heart disease. Though Washkansky…


As a whole, the organ transplant industry isn’t perfect. But its biggest problem isn’t in surgeries; it’s in the limited supply and seemingly endless demand for the most necessary component — the organ itself. At any given time, tens of thousands of people are on waiting lists for heart and organ transplants. Sadly, many of…


Each year, we come together with friends and family on Thanksgiving Day to, well, give thanks. In addition to giving thanks for our loved ones, we express gratitude for tables full of food, and eat more than we normally would. While you may want to eat at least some of everything on the table in…


Roxanne Watson Heart Transplant Survivor

Roxanne Watson is an amazing woman. She’s just one of millions who have been affected by heart disease globally. But she’s putting her personal story of struggle and triumph to work for others in a major way. After spending two agonizing years on the heart transplant waiting list, Roxanne was able to get the heart…


Sadly, heart disease remains the number one killer in the developed world. It’s the leading cause of death for both men and women. What about cancer? Cardiovascular diseases actually surpass the annual mortality rate of all types of cancer combined. Patients in the late stages of heart failure or severe coronary artery disease can be…


To the layman, “3D bioprinting” may be a strange term that conjures up futuristic images of science fiction. But the fascinating reality is that 3D bioprinting is indeed science fact, and it’s built on a history of advancements across a number of life science and technological disciplines. There’s the biological aspect, which dates back to…

BIOLIFE4D in the News!


The emerging tech company, BIOLIFE4D recently announced it has successfully 3D printed human cardiac tissue. This tissue can be used in people who have acute heart failure to help restore lost heart function. This is a huge step toward 3D printing an actual human heart viable for transplant. Learn more about how 3D printers are…


By Emilia Benton, Correspondent  Updated 10:11 am CDT, Tuesday, October 23, 2018 According to U.S. Government Information on Organ Donation and Transplantation, hundreds of thousands of patients across the U.S. are currently on a waiting list for a transplanted organ, and 20 people die each day waiting for a transplant. However, researchers within the Texas Medical Center…


A 3-D bioprinted cardiac patch may offer healing to patients with acute myocardial infarction as well as pave the way for an entire human heart replacement. Biolife4D has achieved a milestone in its ultimate quest to develop human organs for transplant. The company recently announced that it has developed a cardiac patch using a highly specialized…


Sept. 11th, 2018 Bioprinting has taken off following a dramatic discovery by Shinya Yamanaka and Sir John Gurdon, who a Nobel Prize for their work in 2012. Adult ordinary cells can now be reprogrammed to make stem cells – called induced pluripotent stem cells – which can be used to make any other cell in…


Sept. 6th, 2018 The financial year of 2017/18 saw the highest number of organs ever donated in the UK. However, as organ donation figures continue to rise so too does the demand for transplants. By 2020 a new opt-out system for organ donation could be put in place across England if parliament approves “Max’s Law”. However,…


Jul 3, 2018 Around 20 people in the United States die every day waiting for a replacement organ. There simply aren’t enough people donating organs to save all of these people, but this isn’t even the biggest problem. Donated organs only last so long before the recipient’s body starts rejecting them, and medication can only delay…


July 02, 2018 A Skokie biotech startup is one step closer to its goal of 3-D printing a transplant-worthy human heart. BioLife4D has successfully used 3-D bioprinting technology to create a human cardiac patch, which founder Steven Morris says could ultimately help repair damaged hearts and will be a blueprint for further innovation. Read more…


June 26, 2018 Conceptual Design celebrates the projects that are yet to be realized. They are creative ideas, imagined future states or thought pieces intended to start a conversation. This category rewards the blue sky thinking that is needed to drive design forward. Read more HERE


June 26, 2018  BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully demonstrated its ability to 3D bioprint human cardiac tissue – specifically, a human cardiac patch. Read more HERE


june 26, 2018 According to the American Heart Association, heart disease, also known as cardiovascular disease, refers to a variety of different problems that affect that heart, many of which are connected to atherosclerosis, a condition in which plaque builds up in the walls of the arteries making it difficult for the heart to pump…


June 26, 2018 Biolife4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, has successfully demonstrated its ability to 3D bioprint human cardiac tissue – specifically, a human cardiac patch. The scientific milestone was accomplished within days of the May opening of the company’s new research facility at…


June 25, 2018 BioLife4D announced that it has demonstrated an ability to 3D bioprint human cardiac tissue. The 3D bioprinted human cardiac patch will soon be tested in patients with acute HF to restore myocardial contractility, and the technology could one day lead to 3D bioprinting of an entire human heart, potentially easing the shortage of…


June 25th, 2018 BioLife4D, a biotech company, is working on printing a viable human heart which is suitable for transplant. But, the company claims to have reached a significant milestone and successfully 3D bioprinted a human cardiac patch.  Read more HERE  


June 25, 2018: Biotech 3D printing startup BioLife4D has successfully produced human tissue in the form of a cardiac patch, the company announced on Monday, bringing it one step closer to printing organs viable for transplant. “What’s interesting about this is that it’s being 3D bioprinted,” Joseph Woo, MD, the chair of the Department of Cardiothoracic Surgery at Stanford University, told…


As part of a commercialization strategy for its life-saving 3D bioprinting technology, biotech company BIOLIFE4D is now a resident company at the 34,000-square-foot Johnson & Johnson Innovation (JJI) science innovation center (JLABS), located at the Texas Medical Center. BIOLIFE4D is working to make its core mission of 3D printing a viable human heart for transplant a reality, and operating out of Houston…


Regulation A+ (Reg A+) is a funding option that feels tailor-made for high impact technologies like medtech. Never heard of it? That’s because it didn’t exist until 2015, when the Obama administration passed the JOBS Act. Before then, private companies could only seek backing from the wealthiest 2% of Americans — accredited investors. The new…


THE IDEA: Bioprinting fully functioning human hearts to be used for transplants THE AHA MOMENT: Up until seven years ago, Steven Morris owned a company that specialized in machining medical implants and surgical equipment. He became fascinated with 3D printing as a way to create prototypes faster and began to wonder if the same thing could…


It’s been 50 years since Dr. Christiaan Barnard performed the first successful human-to-human heart transplant in South Africa – a procedure that would forever change the way heart disease is treated. Over the last half-century we’ve seen continued innovation in organ transplantation, from tissue typing to the discovery of immunosuppressant drugs, leading to a longer…


We’ve seen 3D printers create toys, sneakers, and even prosthetics. One startup wants to push further by creating a functioning, 3D-printed human heart. Company BioLife4D is working on just that: a printing process that could recreate a beating human heart using a patient’s own cells. Steven Morris, founding partner and CEO of BioLife4D, sees this…


Do you foresee a future when we won’t need to create artificial human organs or harvest them from animals? Well, that future is already here. Cutting-edge companies are using futuristic technology to push the boundaries of 3D bioprinting, potentially making organ donation a thing of the past. To read more click HERE


Interview with Steve Morris – Founder & CEO of BIOLIFE4D. BIOLIFE4D is a biotech startup focused on leveraging advances in life sciences and tissue engineering to 3D bio-print a viable human heart suitable for transplant. Steve Morris is the Founder & CEO of BIOLIFE4D. He has been in the medical field most of his life…


The technology which will print a working heart from a patient’s cells is been developing by Biolife4D Company. A few months later, a laboratory in Chicago will open, which can turn over the history of transplantology. The company consists of medical and science team. Founding partner and CEO is Steven Morris; Chief Medical Officer is…


February 12, 2018 More and more investors and financial advisors are able to get in on early stage companies and initial public offerings thanks to equity crowdfunding, Steven Morris writes on WealthManagement.com. And while many investors treat equity crowdfunding as a decision they make with their heart, advisors can steer them to make sure it’s made smartly…


Feb 5, 2018 | By Tess BIOLIFE4D, a medical tech firm specializing in 3D bioprinting and tissue engineering, is collaborating with Northwestern University through a recently signed “Laboratory Service Agreement” (LSA). Through the partnership, Chicago-based BIOLIFE4D will be given access to Northwestern’s state-of-the-art research facilities and resources. Read more HERE


BIOLIFE4D has started a $50 million Reg A+ offering that will fund its work to create a replacement for the human heart through a 3-D printing process. Down the road, the company sees the potential for replicating other human organs. “Once our process for 3D bioprinting a heart is optimized, we can leverage the technology…


By Steven Morris Equity crowdfunding—and more specifically Regulation A+ deals—has understandably received significant attention over the past few years. Investors and their financial advisors now have access to early stage of companies and initial public offerings, which was previously available only to the wealthy, or those with well-connected advisors who could have shares allocated their…


You can 3-D print chocolate, parts of an airplane, even skin. But what about a human heart? So far, printing one that’s transplant-worthy has been an elusive goal for researchers and companies, despite rapid advancements in technology. Enter Steven Morris, founder and CEO of Skokie startup BioLife4D. He’s busy assembling a team, adding talent from…


BY ADELE PETERS Inside a lab that will open in a couple of months in Chicago, a biotech startup will soon begin perfecting the process of 3D-printing human hearts that could eventually be used in transplants. “What this is set up to do is to make a patient-specific, fully functioning heart that’s viable for transplant,…


Scientists are making progress in the quest to bioprint transplantable human organs. American biotech BIOLIFE4D is trying to establish itself as a world-leader, with CEO Steven Morris saying the company is striving to be the “first to market with a commercially viable 3D bioprinting process”. To advance that goal it added leading biomedical engineer, Adam Feinberg, to its scientific advisory team…


By Bob Marshall, , Chief Editor, Med Device Online Fifty-three percent of women surveyed indicated they would end their relationship if they didn’t get something for Valentine’s Day, according to research conducted by Statistic Brain. Since I am a romantic at heart and a big believer in prevention, I feel it is my civic duty to let…


The heart is one of the most important organs in the human body, and nobody can survive without one. However, it is possible to survive without your own heart, long as you receive a functional one to replace it. On December 3, 1967, Dr. Christiaan Barnard performed the first successful human-to-human heart transplant on 53-year…


Imagine a world where heart transplants do not cost that much and do not have long waiting lists. Imagine not having to go through immunosuppressive therapy following a life and death surgery. Fortunately, we won’t have to imagine these soon as BIOLIFE4D is already developing a technology that could eliminate these concerns and do more…


12. BIOLIFE4D Technology is beginning to tackle heart transplants that stem from conditions like heart disease or failure, potentially saving people time on a heart waiting list. Using 3D bioprinting and bioink, companies like BIOLIFE4D create cell patterns within a construct to make a biological structure that could potentially be used to improve or replace…


BIOLIFE4D announced it filed a $50 million initial public offering with the Securities and Exchange Commission (SEC) under Regulation A+ rules, allowing everyday investors to help the company bring its groundbreaking cardiac tissue regeneration and organ replacement process to market. Chicago-based BIOLIFE4D is a pioneering biotech company focused on leveraging advances in life sciences and…


Imagine a world where heart transplants do not cost that much and do not have long waiting lists. Imagine not having to go through immunosuppressive therapy following a life and death surgery. Fortunately, we won’t have to imagine these soon as BIOLIFE4D is already developing a technology that could eliminate these concerns and do more for…


TechRepublic, a global technology publication highlighting innovation and next generation technologies across multiple industries, recently featured BIOLIFE4D as one of 12 technologies that is revolutionizing the healthcare and medical industry. “Technology is beginning to tackle heart transplants that stem from conditions like heart disease or failure, potentially saving people time on a heart waiting list.” To read…


For 35 years, MD+DI’s editorial quality and reliability have won it an unparalleled degree of trust from the industry. Some of the best and brightest experts in medtech contribute to MD+DI, and many of their articles have become standards of reference for the medical device industry. See MD+DI’s article about BIOLIFE4D here: Is the First…


3DPrint.com, the voice of the 3D printing and additive manufacturing industry, showcased the news of BIOLIFE4D’s equity crowdfunding raise filing with the SEC. The article noted that “Researchers have done just about everything except creating a real, transplantable 3D printed heart, and BIOLIFE4D wants to put all the pieces together to do so.” Read the…


Dr. Ramille Shah, an assistant professor of materials science and engineering at McCormick School of Engineering at Northwestern University, and a member of the BIOLIFE4D Science Team, discussed recent regenerative medicine breakthroughs with CNN in May of 2017. Journalist Susan Scutti proclaimed “a new era of regenerative medicine could be on the horizon,” describing how…


R&D Mag interviewed Dr. Ibrahim Ozbolat, Associate Professor of Engineering Science and Mechanics at Penn State University and member of the BIOLIFE4D Science Team. Dr. Ozbolat discussed recent progress in the world of 3D printing which is enabling biocompatible materials, cells and supporting components to be assembled into functional living tissues. The article described Dr….

Build a Heart. Save a life.

Invest Now

Bioprinter layering bio-ink of human heart cells

Scroll Up